Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001593034-23-000016
Filing Date
2023-05-08
Accepted
2023-05-08 13:06:22
Documents
108
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q endp-20230331.htm   iXBRL 10-Q 2025031
2 EX-31.1 a20230331ex311ceo302cert.htm EX-31.1 8679
3 EX-31.2 a20230331ex312cfo302cert.htm EX-31.2 8696
4 EX-32.1 a20230331ex321ceo906cert.htm EX-32.1 6145
5 EX-32.2 a20230331ex322cfo906cert.htm EX-32.2 6174
  Complete submission text file 0001593034-23-000016.txt   11383801

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT endp-20230331.xsd EX-101.SCH 81486
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT endp-20230331_cal.xml EX-101.CAL 89395
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT endp-20230331_def.xml EX-101.DEF 363182
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT endp-20230331_lab.xml EX-101.LAB 786729
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT endp-20230331_pre.xml EX-101.PRE 579356
102 EXTRACTED XBRL INSTANCE DOCUMENT endp-20230331_htm.xml XML 2286174
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

EIN.: 680683755 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36326 | Film No.: 23896838
SIC: 2834 Pharmaceutical Preparations